382 related articles for article (PubMed ID: 18778785)
21. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
22. BV2 enhanced the neurotrophic functions of mesenchymal stem cells after being stimulated with injured PC12.
Luo X; Ge C; Ren Y; Zhou J; Li X; Yan R; Zhang C
Neuroimmunomodulation; 2009 Jan; 16(1):28-34. PubMed ID: 19077443
[TBL] [Abstract][Full Text] [Related]
23. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
[TBL] [Abstract][Full Text] [Related]
24. Generation of dopaminergic neurons from human fetal mesencephalic progenitors after co-culture with striatal-conditioned media and exposure to lowered oxygen.
Liu S; Tian Z; Yin F; Zhao Q; Fan M
Brain Res Bull; 2009 Aug; 80(1-2):62-8. PubMed ID: 19463914
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.
Xiong N; Cao X; Zhang Z; Huang J; Chen C; Zhang Z; Jia M; Xiong J; Liang Z; Sun S; Lin Z; Wang T
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1519-29. PubMed ID: 20542126
[TBL] [Abstract][Full Text] [Related]
27. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons.
Takeshima T; Shimoda K; Johnston JM; Commissiong JW
J Neurosci Methods; 1996 Jul; 67(1):27-41. PubMed ID: 8844522
[TBL] [Abstract][Full Text] [Related]
28. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
29. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
30. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
[TBL] [Abstract][Full Text] [Related]
31. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression.
Kan I; Ben-Zur T; Barhum Y; Levy YS; Burstein A; Charlow T; Bulvik S; Melamed E; Offen D
Neurosci Lett; 2007 May; 419(1):28-33. PubMed ID: 17475405
[TBL] [Abstract][Full Text] [Related]
33. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
Datta I; Bhonde R
Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
[TBL] [Abstract][Full Text] [Related]
34. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF.
Buytaert-Hoefen KA; Alvarez E; Freed CR
Stem Cells; 2004; 22(5):669-74. PubMed ID: 15342931
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic differentiation of human neural stem cells mediated by co-cultured rat striatal brain slices.
Anwar MR; Andreasen CM; Lippert SK; Zimmer J; Martinez-Serrano A; Meyer M
J Neurochem; 2008 Apr; 105(2):460-70. PubMed ID: 18194213
[TBL] [Abstract][Full Text] [Related]
36. Protection of dopamine neurons by bone marrow stromal cells.
Shintani A; Nakao N; Kakishita K; Itakura T
Brain Res; 2007 Dec; 1186():48-55. PubMed ID: 17996227
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
Gu S; Huang H; Bi J; Yao Y; Wen T
Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
[TBL] [Abstract][Full Text] [Related]
38. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons.
Trzaska KA; King CC; Li KY; Kuzhikandathil EV; Nowycky MC; Ye JH; Rameshwar P
J Neurochem; 2009 Aug; 110(3):1058-69. PubMed ID: 19493166
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.
Lu L; Zhao C; Liu Y; Sun X; Duan C; Ji M; Zhao H; Xu Q; Yang H
Brain Res Brain Res Protoc; 2005 May; 15(1):46-51. PubMed ID: 15878150
[TBL] [Abstract][Full Text] [Related]
40. Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells.
Rivera FJ; Sierralta WD; Minguell JJ; Aigner L
Neurosci Lett; 2006 Oct; 406(1-2):49-54. PubMed ID: 16916578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
